Korro Bio, Inc.
KRRO
$14.48
$0.372.62%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.82M | 2.27M | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.82M | 2.27M | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 4.82M | 2.27M | -- | -- | -- |
| SG&A Expenses | 41.84M | 41.87M | 45.08M | 42.67M | 40.36M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 100.30M | 94.18M | 95.76M | 91.62M | 85.90M |
| Operating Income | -95.48M | -91.91M | -95.76M | -91.62M | -85.90M |
| Income Before Tax | -87.29M | -83.44M | -87.77M | -85.25M | -81.08M |
| Income Tax Expenses | 124.00K | 141.00K | 38.00K | 47.00K | 44.00K |
| Earnings from Continuing Operations | -87.41 | -83.58 | -87.81 | -85.30 | -81.12 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -87.41M | -83.58M | -87.81M | -85.30M | -81.12M |
| EBIT | -95.48M | -91.91M | -95.76M | -91.62M | -85.90M |
| EBITDA | -91.41M | -88.35M | -92.47M | -88.27M | -82.36M |
| EPS Basic | -9.44 | -9.39 | -11.94 | -74.76 | -136.16 |
| Normalized Basic EPS | -5.89 | -5.86 | -7.46 | -46.72 | -85.04 |
| EPS Diluted | -9.44 | -9.39 | -11.94 | -74.76 | -136.16 |
| Normalized Diluted EPS | -5.89 | -5.86 | -7.46 | -46.72 | -85.04 |
| Average Basic Shares Outstanding | 37.04M | 35.68M | 31.59M | 22.58M | 13.87M |
| Average Diluted Shares Outstanding | 37.04M | 35.68M | 31.59M | 22.58M | 13.87M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |